Kurkó J, Besenyei T, Laki J, Glant TT, Mikecz K, Szekanecz Z. (2013. October). „Genetics of rheumatoid arthritis - a comprehensive review.” (angol nyelven). Clin Rev Allergy Immunol.45 (2), 170-9. o. DOI:10.1007/s12016-012-8346-7. PMID23288628.
Carbonell J, Cobo T, Balsa A, Descalzo MA, Carmona L; SERAP Study Group. (2008. July). „The incidence of rheumatoid arthritis in Spain: results from a nationwide primary care registry.” (angol nyelven). Rheumatology (Oxford).47 (7), 1088-92. o. DOI:10.1093/rheumatology/ken205. PMID18511475.
Pedersen JK, Kjaer NK, Svendsen AJ, Hørslev-Petersen K. (2009. February). „Incidence of rheumatoid arthritis from 1995 to 2001: impact of ascertainment from multiple sources.” (angol nyelven). Rheumatol Int.29 (4), 411-5. o. DOI:10.1007/s00296-008-0713-6. PMID18853167.
Young A, Koduri G. (2007. October). „Extra-articular manifestations and complications of rheumatoid arthritis.” (angol nyelven). Best Pract Res Clin Rheumatol.21 (5), 907-27. o. DOI:10.1016/j.berh.2007.05.007. PMID17870035.
Caucanas M, Heylen A, Rolland F, Müller G, Olemans C, Sass U, Vanhooteghem O. (2013. October). „Associated pyoderma gangrenosum, erythema elevatum diutinum, and Sweet's syndrome: the concept of neutrophilic disease.” (angol nyelven). Int J Dermatol.52 (10), 1185-8. o. DOI:10.1111/j.1365-4632.2011.05415.x. PMID24073904.
Schreiber J, Koschel D, Kekow J, Waldburg N, Goette A, Merget R. (2010. June). „Rheumatoid pneumoconiosis (Caplan's syndrome).” (angol nyelven). Eur J Intern Med.21 (3), 168-72. o. DOI:10.1016/j.ejim.2010.02.004. PMID20493416.
Solomon DH, Karlson EW, Rimm EB, et al. (2003. March). „Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis.” (angol nyelven). Circulation.107 (9), 1303-7. o. DOI:10.1161/01.CIR.0000054612.26458.B2. PMID12628952.
Aviña-Zubieta JA, Choi HK, Sadatsafavi M, et al. (2008. December). „Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies.” (angol nyelven). Arthritis Rheum.59 (12), 1690-7. o. DOI:10.1002/art.24092. PMID19035419.
Sen D, González-Mayda M, Brasington RD Jr. (2014. February). „Cardiovascular disease in rheumatoid arthritis.” (angol nyelven). Rheum Dis Clin North Am.40 (1), 27-49. o. DOI:10.1016/j.rdc.2013.10.005. PMID24268008.
Choy E, Ganeshalingam K, Semb AG, Szekanecz Z, Nurmohamed M. (2014. December). „Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment.” (angol nyelven). Rheumatology (Oxford).53 (12), 2143-54. o. DOI:10.1093/rheumatology/keu224. PMID24907149.
Ntatsaki E, Mooney J, Scott DG, Watts RA. (2014. January). „Systemic rheumatoid vasculitis in the era of modern immunosuppressive therapy.” (angol nyelven). Rheumatology (Oxford).53 (1), 145-52. o. DOI:10.1093/rheumatology/ket326. PMID24108586.
Artifoni M, Rothschild PR, Brézin A, Guillevin L, Puéchal X. (2014. February). „Ocular inflammatory diseases associated with rheumatoid arthritis.” (angol nyelven). Nat Rev Rheumatol.10 (2), 108-16. o. DOI:10.1038/nrrheum.2013.185. PMID24323074.
Real de Asúa D, Costa R, Galván JM, Filigheddu MT, Trujillo D, Cadiñanos J. (2014. October). „Systemic AA amyloidosis: epidemiology, diagnosis, and management.” (angol nyelven). Clin Epidemiol.6, 368-77. o. DOI:10.2147/CLEP.S39981. PMID25378951.
Mittal T, Rathi M. (2014. June). „Rheumatological diseases and kidneys: a nephrologist's perspective.” (angol nyelven). Int J Rheum Dis.. DOI:10.1111/1756-185X.12424. PMID24952962.
Ramos-Remus C, Duran-Barragan S, Castillo-Ortiz JD. (2012. January). „Beyond the joints: neurological involvement in rheumatoid arthritis.” (angol nyelven). Clin Rheumatol.31 (1), 1-12. o. DOI:10.1007/s10067-011-1841-z. PMID21932019.
Muramatsu K, Tanaka H, Taguchi T. (2008. August). „Peripheral neuropathies of the forearm and hand in rheumatoid arthritis: diagnosis and options for treatment.” (angol nyelven). Rheumatol Int.28 (10), 951-7. o. DOI:10.1007/s00296-008-0630-8. PMID18528693.
Korczowska I. (2014. September). „Rheumatoid arthritis susceptibility genes: An overview.” (angol nyelven). World J Orthop.5 (4), 544-9. o. DOI:10.5312/wjo.v5.i4.544. PMID25232530.
Kapitány A, Zilahi E, Szántó S, Szücs G, Szabó Z, Végvári A, Rass P, Sipka S, Szegedi G, Szekanecz Z. (2005. June). „Association of rheumatoid arthritis with HLA-DR1 and HLA-DR4 in Hungary.” (angol nyelven). Ann N Y Acad Sci.1051, 263-70. o. DOI:10.1196/annals.1361.067. PMID16126967.
Song GG, Bae SC, Kim JH, Lee YH. (2013. August). „The PTPN22 C1858T polymorphism and rheumatoid arthritis: a meta-analysis” (angol nyelven). Rheumatol Int.33 (8), 1991-9. o. DOI:10.1007/s00296-013-2679-2. PMID23370857.
Scher JU, Abramson SB. (2011. August). „The microbiome and rheumatoid arthritis.” (angol nyelven). Nat Rev Rheumatol.7 (10), 569-78. o. DOI:10.1038/nrrheum.2011.121. PMID21862983.
Gatenby P, Lucas R, Swaminathan A. (2013. March). „Vitamin D deficiency and risk for rheumatic diseases: an update.” (angol nyelven). Curr Opin Rheumatol.25 (2), 184-91. o. DOI:10.1097/BOR.0b013e32835cfc16. PMID23370372.
Cutolo M. (2009. March). „Vitamin D and autoimmune rheumatic diseases.” (angol nyelven). Rheumatology (Oxford).48 (3), 210-2. o. DOI:10.1093/rheumatology/ken394. PMID18930963.
Turesson C, Bergström U, Jacobsson LT, Truedsson L, Berglund G, Saxne T. (2011. March). „Increased cartilage turnover and circulating autoantibodies in different subsets before the clinical onset of rheumatoid arthritis.” (angol nyelven). Ann Rheum Dis.70 (3), 520-2. o. DOI:10.1136/ard.2010.131896. PMID21081527.
Nielen MM, van Schaardenburg D, Reesink HW, et al. (2004. August). „Increased levels of C-reactive protein in serum from blood donors before the onset of rheumatoid arthritis.” (angol nyelven). Arthritis Rheum.50 (8), 2423-7. o. DOI:10.1136/ard.2010.131896. PMID15334453.
Demoruelle MK, Deane KD, Holers VM. (2014. January). „When and where does inflammation begin in rheumatoid arthritis?” (angol nyelven). Curr Opin Rheumatol.26 (1), 64-71. o. DOI:10.1097/BOR.0000000000000017. PMID24247116.
de Smit M, Westra J, Vissink A, et al. (2012. October). „Periodontitis in established rheumatoid arthritis patients: a cross-sectional clinical, microbiological and serological study.” (angol nyelven). Arthritis Res Ther.14 (5), R222. o. DOI:10.1186/ar4061. PMID23075462.
Wegner N, Wait R, Sroka A, et al. (2010. September). „Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis.” (angol nyelven). Arthritis Rheum.62 (9), 2662-72. o. DOI:10.1002/art.27552. PMID20506214.
Arnett FC, Edworthy SM, Bloch DA, et al. (1988. March). „The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.” (angol nyelven). Arthritis Rheum.31 (3), 315-24. o. DOI:10.1136/ard.2010.138461. PMID3358796.
Aletaha D, Neogi T, Silman AJ, et al. (2010. September). „2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.” (angol nyelven). Ann Rheum Dis.69 (9), 1580-8. o. DOI:10.1136/ard.2010.138461. PMID20699241.
Pratt AG, Isaacs JD. (2014. August). „Seronegative rheumatoid arthritis: Pathogenetic and therapeutic aspects.” (angol nyelven). Best Pract Res Clin Rheumatol.28 (4), 651-9. o. DOI:10.1016/j.berh.2014.10.016. PMID25481556.
Nishimura K, Sugiyama D, Kogata Y, et al. (2007. June). „Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis.” (angol nyelven). Ann Intern Med.146 (11), 797-808. o. DOI:10.7326/0003-4819-146-11-200706050-00008. PMID17548411.
Aggarwal R, Liao K, Nair R, Ringold S, Costenbader KH. (2009. November). „Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis.” (angol nyelven). Arthritis Rheum.61 (11), 1472-83. o. DOI:10.1002/art.24827. PMID19877103.
Ory PA. (2003. July). „Interpreting radiographic data in rheumatoid arthritis.” (angol nyelven). Ann Rheum Dis.62 (7), 597-604. o. DOI:10.1136/ard.62.7.597. PMID12810418.
Sakellariou G, Montecucco C. (2014. January-February). „Ultrasonography in rheumatoid arthritis.” (angol nyelven). Clin Exp Rheumatol.32 (1 Suppl 80), s20-5. o. DOI:10.1136/ard.62.7.597. PMID24528527.
Tan YK, Ostergaard M, Bird P, Conaghan PG. (2014. January-February). „Ultrasound versus high field magnetic resonance imaging in rheumatoid arthritis.” (angol nyelven). Clin Exp Rheumatol.32 (1 Suppl 80), s99-105. o. DOI:10.1136/ard.62.7.597. PMID24528508.
Yazici Y, Simsek I. (2013. January). „Tools for monitoring remission in rheumatoid arthritis: any will do, let's just pick one and start measuring.” (angol nyelven). Arthritis Res Ther.15 (1), 104. o. DOI:10.1186/ar4139. PMID23374997.
Smolen JS, Landewé R, Breedveld FC, et al. (2014. March). „EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update.” (angol nyelven). Ann Rheum Dis.73 (3), 492-509. o. DOI:10.1136/annrheumdis-2013-204573. PMID24161836.
Hurkmans E, van der Giesen FJ, Vliet Vlieland TP, et al. (2009. October). „Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid arthritis.” (angol nyelven). Cochrane Database Syst Rev.4, CD006853. o. DOI:10.1002/14651858.CD006853.pub2. PMID19821388.
Cramp F, Hewlett S, Almeida C, et al. (2013. August). „Non-pharmacological interventions for fatigue in rheumatoid arthritis.” (angol nyelven). Cochrane Database Syst Rev.7, CD008322. o. DOI:10.1002/14651858.CD008322.pub2. PMID23975674.
Macedo AM, Oakley SP, Panayi GS, Kirkham BW. (2009. November). „Functional and work outcomes improve in patients with rheumatoid arthritis who receive targeted, comprehensive occupational therapy.” (angol nyelven). Arthritis Rheum.61 (11), 1522-30. o. DOI:10.1002/art.24563. PMID19877106.
Helewa A, Goldsmith CH, Lee P, et al. (1991. June). „Effects of occupational therapy home service on patients with rheumatoid arthritis.” (angol nyelven). Lancet.337 (8755), 1453-6. o. DOI:10.1016/0140-6736(91)93138-Y. PMID1675329.
Steultjens EM, Dekker J, Bouter LM, et al. (2004). „Occupational therapy for rheumatoid arthritis.” (angol nyelven). Cochrane Database Syst Rev.1, CD003114. o. DOI:10.1002/14651858.CD003114.pub2. PMID14974005.
Gramling A, O'Dell JR. (2012. May). „Initial management of rheumatoid arthritis.” (angol nyelven). Rheum Dis Clin North Am.38 (2), 311-25. o. DOI:10.1016/j.rdc.2012.05.003. PMID22819086.
Smolen JS, van der Heijde D, Machold KP, Aletaha D, Landewé R. (2014. January). „Proposal for a new nomenclature of disease-modifying antirheumatic drugs.” (angol nyelven). Ann Rheum Dis.73 (1), 3-5. o. DOI:10.1136/annrheumdis-2013-204317. PMID24072562.
Pincus T, Yazici Y, Sokka T, Aletaha D, Smolen JS. (2003. September-October). „Methotrexate as the "anchor drug" for the treatment of early rheumatoid arthritis.” (angol nyelven). Clin Exp Rheumatol.21 (5 Suppl 31), s179-85. o. DOI:10.1136/annrheumdis-2013-204317. PMID14969073.
Kavanaugh A, Fleischmann RM, Emery P, Kupper H, Redden L, Guerette B, Santra S, Smolen JS. (2013. January). „Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA study.” (angol nyelven). Ann Rheum Dis.72 (1), 64-71. o. DOI:10.1136/annrheumdis-2011-201247. PMID22562973.
Shea B, Swinden MV, Tanjong Ghogomu E, et al. (2013. May). „Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.” (angol nyelven). Cochrane Database Syst Rev.5, CD000951. o. DOI:10.1002/14651858.CD000951.pub2. PMID23728635.
Salliot C, van der Heijde D. (2009. July). „Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research.” (angol nyelven). Ann Rheum Dis.68 (7), 1100-4. o. DOI:10.1136/ard.2008.093690. PMID19060002.
Smolen JS, Kalden JR, Scott DL, et al. (1999. January). „Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.” (angol nyelven). Lancet.353 (9149), 259-66. o. DOI:10.1016/S0140-6736(98)09403-3. PMID9929017.
Katz SJ, Russell AS. (2011. May). „Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action.” (angol nyelven). Curr Opin Rheumatol.23 (3), 278-81. o. DOI:10.1097/BOR.0b013e32834456bf. PMID21448012.
Aaltonen KJ, Virkki LM, Malmivaara A, et al. (2012). „Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis.” (angol nyelven). PLoS One.7 (1), e30275. o. DOI:10.1371/journal.pone.0030275. PMID22272322.
Desai SB, Furst DE. (2006. August). „Problems encountered during anti-tumour necrosis factor therapy.” (angol nyelven). Best Pract Res Clin Rheumatol.20 (4), 757-90. o. DOI:10.1016/j.berh.2006.06.002. PMID16979537.
Askling J, Fahrbach K, Nordstrom B, et al. (2011. February). „Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data.” (angol nyelven). Pharmacoepidemiol Drug Saf.20 (2), 119-30. o. DOI:10.1002/pds.2046. PMID21254282.
Atzeni F, Talotta R, Salaffi F, et al. (2013. May). „Immunogenicity and autoimmunity during anti-TNF therapy.” (angol nyelven). Autoimmun Rev.12 (7), 703-8. o. DOI:10.1016/j.autrev.2012.10.021. PMID23207283.
Keiserman M, Codreanu C, Handa R, et al. (2014. August). „The effect of antidrug antibodies on the sustainable efficacy of biologic therapies in rheumatoid arthritis: practical consequences.” (angol nyelven). Expert Rev Clin Immunol.10 (8), 1049-57. o. DOI:110.1586/1744666X.2014.926219. PMID24961616.
Edwards JC, Szczepanski L, Szechinski J, et al. (2004. June). „Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.” (angol nyelven). N Engl J Med.350 (25), 2572-81. o. DOI:10.1056/NEJMoa032534. PMID15201414.
Wang D, Li Y, Liu Y, Shi G. (2014). „The use of biologic therapies in the treatment of rheumatoid arthritis.” (angol nyelven). Curr Pharm Biotechnol.15 (6), 542-8. o. DOI:10.2174/138920101506140910150612. PMID25213363.
Chen YF, Jobanputra P, Barton P, et al. (2008. April). „Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.” (angol nyelven). Health Technol Assess.12 (11), 1-278. o. DOI:10.3310/hta12110. PMID18405470.
Trelle S, Reichenbach S, Wandel S, et al. (2011. January). „Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis.” (angol nyelven). BMJ.342, c7086. o. DOI:10.1136/bmj.c7086. PMID21224324.
Kavanaugh A, Wells AF. (2014. October). „Benefits and risks of low-dose glucocorticoid treatment in the patient with rheumatoid arthritis.” (angol nyelven). Rheumatology (Oxford).53 (10), 1742-51. o. DOI:10.1093/rheumatology/keu135. PMID24729402.
Macfarlane GJ, Paudyal P, Doherty M, et al. (2012. September). „A systematic review of evidence for the effectiveness of practitioner-based complementary and alternative therapies in the management of rheumatic diseases: rheumatoid arthritis.” (angol nyelven). Rheumatology (Oxford).51 (9), 1707-13. o. DOI:10.1093/rheumatology/kes133. PMID22661556.
Cameron M, Gagnier JJ, Chrubasik S. (2011. February). „Herbal therapy for treating rheumatoid arthritis.” (angol nyelven). Cochrane Database Syst Rev.2, CD002948. o. DOI:10.1002/14651858.CD002948.pub2. PMID21328257.
Brien S, Lachance L, Prescott P, McDermott C, Lewith G. (2011. June). „Homeopathy has clinical benefits in rheumatoid arthritis patients that are attributable to the consultation process but not the homeopathic remedy: a randomized controlled clinical trial.” (angol nyelven). Rheumatology (Oxford).50 (6), 1070-82. o. DOI:10.1093/rheumatology/keq234. PMID21076131.
Mitchell K, Kaul M, Clowse ME. (2010. March). „The management of rheumatic diseases in pregnancy.” (angol nyelven). Scand J Rheumatol.39 (2), 99-108. o. DOI:10.3109/03009740903449313. PMID20337545.
Entezami P, Fox DA, Clapham PJ, Chung KC. (2011. February). „Historical perspective on the etiology of rheumatoid arthritis.” (angol nyelven). Hand Clin.27 (1), 1-10. o. DOI:10.1016/j.hcl.2010.09.006. PMID21176794.
Takeuchi T. (2011). „Revolutionary change in rheumatoid arthritis management with biological therapy.” (angol nyelven). Keio J Med.60 (3), 75-81. o. PMID21979826.
Gabriel SE. (2001. May). „The epidemiology of rheumatoid arthritis.” (angol nyelven). Rheum Dis Clin North Am.27 (2), 269-81. o. PMID11396092.
Gibofsky A. (2012. December). „Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis.” (angol nyelven). Am J Manag Care.18 (13 (Suppl)), S295-302. o. PMID23327517.
Alamanos Y, Voulgari PV, Drosos AA. (2006. December). „Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review.” (angol nyelven). Semin Arthritis Rheum.36 (3), 182-8. o. PMID17045630.
Symmons DP. (2002. December). „Epidemiology of rheumatoid arthritis: determinants of onset, persistence and outcome.” (angol nyelven). Best Pract Res Clin Rheumatol.16 (5), 707-22. o. PMID12473269.
Carbonell J, Cobo T, Balsa A, Descalzo MA, Carmona L; SERAP Study Group. (2008. July). „The incidence of rheumatoid arthritis in Spain: results from a nationwide primary care registry.” (angol nyelven). Rheumatology (Oxford).47 (7), 1088-92. o. DOI:10.1093/rheumatology/ken205. PMID18511475.
Pedersen JK, Kjaer NK, Svendsen AJ, Hørslev-Petersen K. (2009. February). „Incidence of rheumatoid arthritis from 1995 to 2001: impact of ascertainment from multiple sources.” (angol nyelven). Rheumatol Int.29 (4), 411-5. o. DOI:10.1007/s00296-008-0713-6. PMID18853167.
Alamanos Y, Drosos AA. (2005. March). „Epidemiology of adult rheumatoid arthritis.” (angol nyelven). Autoimmun Rev.4 (3), 130-6. o. PMID15823498.
Young A, Koduri G. (2007. October). „Extra-articular manifestations and complications of rheumatoid arthritis.” (angol nyelven). Best Pract Res Clin Rheumatol.21 (5), 907-27. o. DOI:10.1016/j.berh.2007.05.007. PMID17870035.
Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD, Tanasescu R. (2010. December). „Extra-articular Manifestations in Rheumatoid Arthritis.” (angol nyelven). Maedica (Buchar).5 (4), 286-91. o. PMID21977172.
Caucanas M, Heylen A, Rolland F, Müller G, Olemans C, Sass U, Vanhooteghem O. (2013. October). „Associated pyoderma gangrenosum, erythema elevatum diutinum, and Sweet's syndrome: the concept of neutrophilic disease.” (angol nyelven). Int J Dermatol.52 (10), 1185-8. o. DOI:10.1111/j.1365-4632.2011.05415.x. PMID24073904.
Kremer JM, Alarcón GS, Weinblatt ME, et al. (1997. October). „Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review.” (angol nyelven). Arthritis Rheum.40 (10), 1829-37. o. PMID9336418.
Ondrasík M. (1989. April). „Caplan's syndrome.” (angol nyelven). Baillieres Clin Rheumatol.3 (1), 205-10. o. PMID2661027.
Schreiber J, Koschel D, Kekow J, Waldburg N, Goette A, Merget R. (2010. June). „Rheumatoid pneumoconiosis (Caplan's syndrome).” (angol nyelven). Eur J Intern Med.21 (3), 168-72. o. DOI:10.1016/j.ejim.2010.02.004. PMID20493416.
Solomon DH, Karlson EW, Rimm EB, et al. (2003. March). „Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis.” (angol nyelven). Circulation.107 (9), 1303-7. o. DOI:10.1161/01.CIR.0000054612.26458.B2. PMID12628952.
Aviña-Zubieta JA, Choi HK, Sadatsafavi M, et al. (2008. December). „Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies.” (angol nyelven). Arthritis Rheum.59 (12), 1690-7. o. DOI:10.1002/art.24092. PMID19035419.
Sen D, González-Mayda M, Brasington RD Jr. (2014. February). „Cardiovascular disease in rheumatoid arthritis.” (angol nyelven). Rheum Dis Clin North Am.40 (1), 27-49. o. DOI:10.1016/j.rdc.2013.10.005. PMID24268008.
Chighizola C, Schioppo T, Ingegnoli F, Meroni PL. (2012. September). „Potential effect of anti-inflammatory treatment on reducing the cardiovascular risk in rheumatoid arthritis.” (angol nyelven). Curr Vasc Pharmacol.10 (5), 639-46. o. PMID22272912.
Choy E, Ganeshalingam K, Semb AG, Szekanecz Z, Nurmohamed M. (2014. December). „Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment.” (angol nyelven). Rheumatology (Oxford).53 (12), 2143-54. o. DOI:10.1093/rheumatology/keu224. PMID24907149.
Ntatsaki E, Mooney J, Scott DG, Watts RA. (2014. January). „Systemic rheumatoid vasculitis in the era of modern immunosuppressive therapy.” (angol nyelven). Rheumatology (Oxford).53 (1), 145-52. o. DOI:10.1093/rheumatology/ket326. PMID24108586.
Artifoni M, Rothschild PR, Brézin A, Guillevin L, Puéchal X. (2014. February). „Ocular inflammatory diseases associated with rheumatoid arthritis.” (angol nyelven). Nat Rev Rheumatol.10 (2), 108-16. o. DOI:10.1038/nrrheum.2013.185. PMID24323074.
Real de Asúa D, Costa R, Galván JM, Filigheddu MT, Trujillo D, Cadiñanos J. (2014. October). „Systemic AA amyloidosis: epidemiology, diagnosis, and management.” (angol nyelven). Clin Epidemiol.6, 368-77. o. DOI:10.2147/CLEP.S39981. PMID25378951.
Korpela M, Mustonen J, Teppo AM, Helin H, Pasternack A. (1997. November). „Mesangial glomerulonephritis as an extra-articular manifestation of rheumatoid arthritis.” (angol nyelven). Br J Rheumatol.36 (11), 1189-95. o. PMID9402863.
Mittal T, Rathi M. (2014. June). „Rheumatological diseases and kidneys: a nephrologist's perspective.” (angol nyelven). Int J Rheum Dis.. DOI:10.1111/1756-185X.12424. PMID24952962.
Bowman SJ. (2002). „Hematological manifestations of rheumatoid arthritis.” (angol nyelven). Scand J Rheumatol.31 (5), 251-9. o. PMID12455813.
Wilson A, Yu HT, Goodnough LT, Nissenson AR. (2004. April). „Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature.” (angol nyelven). Am J Med.116 (Suppl 7A), 50S-57S. o. PMID15050886.
Rosenstein ED, Kramer N. (1991. December). „Felty's and pseudo-Felty's syndromes.” (angol nyelven). Semin Arthritis Rheum.21 (3), 129-42. o. PMID1788550.
Balint GP, Balint PV. (2004. October). „Felty's syndrome.” (angol nyelven). Best Pract Res Clin Rheumatol.18 (4), 631-45. o. PMID15454123.
Ramos-Remus C, Duran-Barragan S, Castillo-Ortiz JD. (2012. January). „Beyond the joints: neurological involvement in rheumatoid arthritis.” (angol nyelven). Clin Rheumatol.31 (1), 1-12. o. DOI:10.1007/s10067-011-1841-z. PMID21932019.
Muramatsu K, Tanaka H, Taguchi T. (2008. August). „Peripheral neuropathies of the forearm and hand in rheumatoid arthritis: diagnosis and options for treatment.” (angol nyelven). Rheumatol Int.28 (10), 951-7. o. DOI:10.1007/s00296-008-0630-8. PMID18528693.
Korczowska I. (2014. September). „Rheumatoid arthritis susceptibility genes: An overview.” (angol nyelven). World J Orthop.5 (4), 544-9. o. DOI:10.5312/wjo.v5.i4.544. PMID25232530.
Kapitány A, Zilahi E, Szántó S, Szücs G, Szabó Z, Végvári A, Rass P, Sipka S, Szegedi G, Szekanecz Z. (2005. June). „Association of rheumatoid arthritis with HLA-DR1 and HLA-DR4 in Hungary.” (angol nyelven). Ann N Y Acad Sci.1051, 263-70. o. DOI:10.1196/annals.1361.067. PMID16126967.
Song GG, Bae SC, Kim JH, Lee YH. (2013. August). „The PTPN22 C1858T polymorphism and rheumatoid arthritis: a meta-analysis” (angol nyelven). Rheumatol Int.33 (8), 1991-9. o. DOI:10.1007/s00296-013-2679-2. PMID23370857.
Balandraud N, Roudier J, Roudier C. (2004. July). „Epstein-Barr virus and rheumatoid arthritis.” (angol nyelven). Autoimmun Rev.3 (5), 362-7. o. PMID15288002.
Alvarez-Lafuente R, Fernández-Gutiérrez B, de Miguel S, Jover JA, Rollin R, Loza E, Clemente D, Lamas JR. (2005. September). „Potential relationship between herpes viruses and rheumatoid arthritis: analysis with quantitative real time polymerase chain reaction.” (angol nyelven). Ann Rheum Dis.64 (9), 1357-9. o. PMID16100341.
Scher JU, Abramson SB. (2011. August). „The microbiome and rheumatoid arthritis.” (angol nyelven). Nat Rev Rheumatol.7 (10), 569-78. o. DOI:10.1038/nrrheum.2011.121. PMID21862983.
Gatenby P, Lucas R, Swaminathan A. (2013. March). „Vitamin D deficiency and risk for rheumatic diseases: an update.” (angol nyelven). Curr Opin Rheumatol.25 (2), 184-91. o. DOI:10.1097/BOR.0b013e32835cfc16. PMID23370372.
Cutolo M. (2009. March). „Vitamin D and autoimmune rheumatic diseases.” (angol nyelven). Rheumatology (Oxford).48 (3), 210-2. o. DOI:10.1093/rheumatology/ken394. PMID18930963.
Andjelkovic Z, Vojinovic J, Pejnovic N, Popovic M, Dujic A, Mitrovic D, Pavlica L, Stefanovic D. (1999. July-August). „Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients.” (angol nyelven). Clin Exp Rheumatol.17 (4), 453-6. o. PMID10464556.
Turesson C, Bergström U, Jacobsson LT, Truedsson L, Berglund G, Saxne T. (2011. March). „Increased cartilage turnover and circulating autoantibodies in different subsets before the clinical onset of rheumatoid arthritis.” (angol nyelven). Ann Rheum Dis.70 (3), 520-2. o. DOI:10.1136/ard.2010.131896. PMID21081527.
Nielen MM, van Schaardenburg D, Reesink HW, et al. (2004. August). „Increased levels of C-reactive protein in serum from blood donors before the onset of rheumatoid arthritis.” (angol nyelven). Arthritis Rheum.50 (8), 2423-7. o. DOI:10.1136/ard.2010.131896. PMID15334453.
Demoruelle MK, Deane KD, Holers VM. (2014. January). „When and where does inflammation begin in rheumatoid arthritis?” (angol nyelven). Curr Opin Rheumatol.26 (1), 64-71. o. DOI:10.1097/BOR.0000000000000017. PMID24247116.
de Smit M, Westra J, Vissink A, et al. (2012. October). „Periodontitis in established rheumatoid arthritis patients: a cross-sectional clinical, microbiological and serological study.” (angol nyelven). Arthritis Res Ther.14 (5), R222. o. DOI:10.1186/ar4061. PMID23075462.
Wegner N, Wait R, Sroka A, et al. (2010. September). „Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis.” (angol nyelven). Arthritis Rheum.62 (9), 2662-72. o. DOI:10.1002/art.27552. PMID20506214.
Arnett FC, Edworthy SM, Bloch DA, et al. (1988. March). „The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.” (angol nyelven). Arthritis Rheum.31 (3), 315-24. o. DOI:10.1136/ard.2010.138461. PMID3358796.
Aletaha D, Neogi T, Silman AJ, et al. (2010. September). „2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.” (angol nyelven). Ann Rheum Dis.69 (9), 1580-8. o. DOI:10.1136/ard.2010.138461. PMID20699241.
Nishimura K, Sugiyama D, Kogata Y, et al. (2007. June). „Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis.” (angol nyelven). Ann Intern Med.146 (11), 797-808. o. DOI:10.7326/0003-4819-146-11-200706050-00008. PMID17548411.
Aggarwal R, Liao K, Nair R, Ringold S, Costenbader KH. (2009. November). „Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis.” (angol nyelven). Arthritis Rheum.61 (11), 1472-83. o. DOI:10.1002/art.24827. PMID19877103.
Ory PA. (2003. July). „Interpreting radiographic data in rheumatoid arthritis.” (angol nyelven). Ann Rheum Dis.62 (7), 597-604. o. DOI:10.1136/ard.62.7.597. PMID12810418.
Sakellariou G, Montecucco C. (2014. January-February). „Ultrasonography in rheumatoid arthritis.” (angol nyelven). Clin Exp Rheumatol.32 (1 Suppl 80), s20-5. o. DOI:10.1136/ard.62.7.597. PMID24528527.
Tan YK, Ostergaard M, Bird P, Conaghan PG. (2014. January-February). „Ultrasound versus high field magnetic resonance imaging in rheumatoid arthritis.” (angol nyelven). Clin Exp Rheumatol.32 (1 Suppl 80), s99-105. o. DOI:10.1136/ard.62.7.597. PMID24528508.
Rezaei H, Torp-Pedersen S, Af Klint E, et al. (2014. October). „Diagnostic utility of musculoskeletal ultrasound in patients with suspected arthritis - a probabilistic approach.” (angol nyelven). Arthritis Res Ther.16 (5), 448. o. PMID25270355.
Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. (1995. January). „Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.” (angol nyelven). Arthritis Rheum.38 (1), 44-8. o. PMID7818570.
Yazici Y, Simsek I. (2013. January). „Tools for monitoring remission in rheumatoid arthritis: any will do, let's just pick one and start measuring.” (angol nyelven). Arthritis Res Ther.15 (1), 104. o. DOI:10.1186/ar4139. PMID23374997.
Smolen JS, Landewé R, Breedveld FC, et al. (2014. March). „EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update.” (angol nyelven). Ann Rheum Dis.73 (3), 492-509. o. DOI:10.1136/annrheumdis-2013-204573. PMID24161836.
Hurkmans E, van der Giesen FJ, Vliet Vlieland TP, et al. (2009. October). „Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid arthritis.” (angol nyelven). Cochrane Database Syst Rev.4, CD006853. o. DOI:10.1002/14651858.CD006853.pub2. PMID19821388.
Cramp F, Hewlett S, Almeida C, et al. (2013. August). „Non-pharmacological interventions for fatigue in rheumatoid arthritis.” (angol nyelven). Cochrane Database Syst Rev.7, CD008322. o. DOI:10.1002/14651858.CD008322.pub2. PMID23975674.
Backman CL. (2004. March). „Employment and work disability in rheumatoid arthritis.” (angol nyelven). Curr Opin Rheumatol.16 (2), 148-52. o. PMID14770102.
Macedo AM, Oakley SP, Panayi GS, Kirkham BW. (2009. November). „Functional and work outcomes improve in patients with rheumatoid arthritis who receive targeted, comprehensive occupational therapy.” (angol nyelven). Arthritis Rheum.61 (11), 1522-30. o. DOI:10.1002/art.24563. PMID19877106.
Helewa A, Goldsmith CH, Lee P, et al. (1991. June). „Effects of occupational therapy home service on patients with rheumatoid arthritis.” (angol nyelven). Lancet.337 (8755), 1453-6. o. DOI:10.1016/0140-6736(91)93138-Y. PMID1675329.
Steultjens EM, Dekker J, Bouter LM, et al. (2004). „Occupational therapy for rheumatoid arthritis.” (angol nyelven). Cochrane Database Syst Rev.1, CD003114. o. DOI:10.1002/14651858.CD003114.pub2. PMID14974005.
Gramling A, O'Dell JR. (2012. May). „Initial management of rheumatoid arthritis.” (angol nyelven). Rheum Dis Clin North Am.38 (2), 311-25. o. DOI:10.1016/j.rdc.2012.05.003. PMID22819086.
Smolen JS, van der Heijde D, Machold KP, Aletaha D, Landewé R. (2014. January). „Proposal for a new nomenclature of disease-modifying antirheumatic drugs.” (angol nyelven). Ann Rheum Dis.73 (1), 3-5. o. DOI:10.1136/annrheumdis-2013-204317. PMID24072562.
Pincus T, Yazici Y, Sokka T, Aletaha D, Smolen JS. (2003. September-October). „Methotrexate as the "anchor drug" for the treatment of early rheumatoid arthritis.” (angol nyelven). Clin Exp Rheumatol.21 (5 Suppl 31), s179-85. o. DOI:10.1136/annrheumdis-2013-204317. PMID14969073.
Breedveld FC, Weisman MH, Kavanaugh AF, Cohen SB, Pavelka K, van Vollenhoven R, Sharp J, Perez JL, Spencer-Green GT. (2006. January). „The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment.” (angol nyelven). Arthritis Rheum.54 (1), 26-37. o. PMID16385520.
Kavanaugh A, Fleischmann RM, Emery P, Kupper H, Redden L, Guerette B, Santra S, Smolen JS. (2013. January). „Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA study.” (angol nyelven). Ann Rheum Dis.72 (1), 64-71. o. DOI:10.1136/annrheumdis-2011-201247. PMID22562973.
van Ede AE, Laan RF, Rood MJ, Huizinga TW, et al. (2001. July). „Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study.” (angol nyelven). Arthritis Rheum.44 (7), 1515-24. o. PMID11465701.
Shea B, Swinden MV, Tanjong Ghogomu E, et al. (2013. May). „Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.” (angol nyelven). Cochrane Database Syst Rev.5, CD000951. o. DOI:10.1002/14651858.CD000951.pub2. PMID23728635.
Salliot C, van der Heijde D. (2009. July). „Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research.” (angol nyelven). Ann Rheum Dis.68 (7), 1100-4. o. DOI:10.1136/ard.2008.093690. PMID19060002.
Visser K, van der Heijde DM. (2009. November-December). „Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature.” (angol nyelven). Clin Exp Rheumatol.27 (6), 1017-25. o. PMID20149325.
Smolen JS, Kalden JR, Scott DL, et al. (1999. January). „Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.” (angol nyelven). Lancet.353 (9149), 259-66. o. DOI:10.1016/S0140-6736(98)09403-3. PMID9929017.
Cohen S, Cannon GW, Schiff M, et al. (2001. September). „Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.” (angol nyelven). Arthritis Rheum.44 (9), 1984-92. o. PMID11592358.
Katz SJ, Russell AS. (2011. May). „Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action.” (angol nyelven). Curr Opin Rheumatol.23 (3), 278-81. o. DOI:10.1097/BOR.0b013e32834456bf. PMID21448012.
Aaltonen KJ, Virkki LM, Malmivaara A, et al. (2012). „Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis.” (angol nyelven). PLoS One.7 (1), e30275. o. DOI:10.1371/journal.pone.0030275. PMID22272322.
Desai SB, Furst DE. (2006. August). „Problems encountered during anti-tumour necrosis factor therapy.” (angol nyelven). Best Pract Res Clin Rheumatol.20 (4), 757-90. o. DOI:10.1016/j.berh.2006.06.002. PMID16979537.
Askling J, Fahrbach K, Nordstrom B, et al. (2011. February). „Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data.” (angol nyelven). Pharmacoepidemiol Drug Saf.20 (2), 119-30. o. DOI:10.1002/pds.2046. PMID21254282.
Atzeni F, Talotta R, Salaffi F, et al. (2013. May). „Immunogenicity and autoimmunity during anti-TNF therapy.” (angol nyelven). Autoimmun Rev.12 (7), 703-8. o. DOI:10.1016/j.autrev.2012.10.021. PMID23207283.
Keiserman M, Codreanu C, Handa R, et al. (2014. August). „The effect of antidrug antibodies on the sustainable efficacy of biologic therapies in rheumatoid arthritis: practical consequences.” (angol nyelven). Expert Rev Clin Immunol.10 (8), 1049-57. o. DOI:110.1586/1744666X.2014.926219. PMID24961616.
Edwards JC, Szczepanski L, Szechinski J, et al. (2004. June). „Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.” (angol nyelven). N Engl J Med.350 (25), 2572-81. o. DOI:10.1056/NEJMoa032534. PMID15201414.
Wang D, Li Y, Liu Y, Shi G. (2014). „The use of biologic therapies in the treatment of rheumatoid arthritis.” (angol nyelven). Curr Pharm Biotechnol.15 (6), 542-8. o. DOI:10.2174/138920101506140910150612. PMID25213363.
Chen YF, Jobanputra P, Barton P, et al. (2008. April). „Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.” (angol nyelven). Health Technol Assess.12 (11), 1-278. o. DOI:10.3310/hta12110. PMID18405470.
Trelle S, Reichenbach S, Wandel S, et al. (2011. January). „Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis.” (angol nyelven). BMJ.342, c7086. o. DOI:10.1136/bmj.c7086. PMID21224324.
Kavanaugh A, Wells AF. (2014. October). „Benefits and risks of low-dose glucocorticoid treatment in the patient with rheumatoid arthritis.” (angol nyelven). Rheumatology (Oxford).53 (10), 1742-51. o. DOI:10.1093/rheumatology/keu135. PMID24729402.
Macfarlane GJ, Paudyal P, Doherty M, et al. (2012. September). „A systematic review of evidence for the effectiveness of practitioner-based complementary and alternative therapies in the management of rheumatic diseases: rheumatoid arthritis.” (angol nyelven). Rheumatology (Oxford).51 (9), 1707-13. o. DOI:10.1093/rheumatology/kes133. PMID22661556.
Cameron M, Gagnier JJ, Chrubasik S. (2011. February). „Herbal therapy for treating rheumatoid arthritis.” (angol nyelven). Cochrane Database Syst Rev.2, CD002948. o. DOI:10.1002/14651858.CD002948.pub2. PMID21328257.
Brien S, Lachance L, Prescott P, McDermott C, Lewith G. (2011. June). „Homeopathy has clinical benefits in rheumatoid arthritis patients that are attributable to the consultation process but not the homeopathic remedy: a randomized controlled clinical trial.” (angol nyelven). Rheumatology (Oxford).50 (6), 1070-82. o. DOI:10.1093/rheumatology/keq234. PMID21076131.
Ostensen M, Villiger PM. (2007. June). „The remission of rheumatoid arthritis during pregnancy.” (angol nyelven). Semin Immunopathol.29 (2), 185-91. o. PMID17621703.
Förger F, Marcoli N, Gadola S, et al. (2008. July). „Pregnancy induces numerical and functional changes of CD4+CD25 high regulatory T cells in patients with rheumatoid arthritis.” (angol nyelven). Ann Rheum Dis.67 (7), 984-90. o. PMID17971458.
Skomsvoll JF, Ostensen M, Irgens LM, Baste V. (1998). „Obstetrical and neonatal outcome in pregnant patients with rheumatic disease.” (angol nyelven). Scand J Rheumatol Suppl.107, 109-12. o. PMID9759146.
Mitchell K, Kaul M, Clowse ME. (2010. March). „The management of rheumatic diseases in pregnancy.” (angol nyelven). Scand J Rheumatol.39 (2), 99-108. o. DOI:10.3109/03009740903449313. PMID20337545.
Landré-Beauvais AJ. (2001. March). „The first description of rheumatoid arthritis. Unabridged text of the doctoral dissertation presented in 1800.” (angol nyelven). Joint Bone Spine.68 (2), 130-43. o. PMID11324929.
Entezami P, Fox DA, Clapham PJ, Chung KC. (2011. February). „Historical perspective on the etiology of rheumatoid arthritis.” (angol nyelven). Hand Clin.27 (1), 1-10. o. DOI:10.1016/j.hcl.2010.09.006. PMID21176794.